Lacey J V, Frisch M, Brinton L A, Abbas F M, Barnes W A, Gravitt P E, Greenberg M D, Greene S M, Hadjimichael O C, McGowan L, Mortel R, Schwartz P E, Zaino R J, Hildesheim A
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20852-7234, USA.
Cancer Causes Control. 2001 Feb;12(2):153-61. doi: 10.1023/a:1008918310055.
Few studies of smoking and cervical carcinoma have addressed the rare cervical adenocarcinomas or used DNA-based tests to control for human papillomavirus (HPV) infection.
This multicenter case-control study included 124 adenocarcinoma cases, 307 community controls (matched on age, race, and residence to adenocarcinoma cases), and 139 squamous carcinoma cases (matched on age, diagnosis date, clinic, and disease stage to adenocarcinoma cases). Participants completed risk-factor interviews and volunteered cervical samples for PCR-based HPV testing. Polychotomous logistic regression generated adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for both histologic types.
Eighteen percent of adenocarcinoma cases, 43% of squamous carcinoma cases, and 22% of controls were current smokers. After control for HPV and other questionnaire data, adenocarcinomas were consistently inversely associated with smoking (e.g. current: OR = 0.6, 95% CI 0.3-1.1; > or = 1 pack per day: OR = 0.7, 95% CI 0.4-1.3), while squamous carcinomas were positively associated with smoking (e.g. current: OR = 1.6, 95% CI 0.9-2.9; > or = 1 pack per day: OR = 1.8, 95% CI 1.0-3.3). Results in analyses restricted to HPV-positive controls were similar.
Smoking has opposite associations with cervical adenocarcinomas and squamous carcinomas. Although both histologic types are caused by HPV and arise in the cervix, etiologic co-factors for these tumors may differ.
关于吸烟与宫颈癌的研究中,很少有涉及罕见宫颈腺癌的,或使用基于DNA的检测来控制人乳头瘤病毒(HPV)感染情况的。
这项多中心病例对照研究纳入了124例腺癌病例、307名社区对照者(在年龄、种族和居住地方面与腺癌病例匹配)以及139例鳞癌病例(在年龄、诊断日期、诊所和疾病分期方面与腺癌病例匹配)。参与者完成了危险因素访谈,并自愿提供宫颈样本用于基于PCR的HPV检测。多分类逻辑回归分析得出了两种组织学类型的校正比值比(OR)和95%置信区间(CI)。
18%的腺癌病例、43%的鳞癌病例和22%的对照者为当前吸烟者。在控制了HPV和其他问卷数据后,腺癌与吸烟始终呈负相关(例如,当前吸烟者:OR = 0.6,95% CI 0.3 - 1.1;每天≥1包:OR = 0.7,95% CI 0.4 - 1.3),而鳞癌与吸烟呈正相关(例如,当前吸烟者:OR = 1.6,95% CI 0.9 - 2.9;每天≥1包:OR = 1.8,95% CI 1.0 - 3.3)。在仅限于HPV阳性对照者的分析中结果相似。
吸烟与宫颈腺癌和鳞癌存在相反的关联。尽管这两种组织学类型均由HPV引起且发生于宫颈,但这些肿瘤的病因协同因素可能不同。